During the past year notable progress was made in several laboratories on design for linear accelerators in the energy range up to and above 1 Bev. Interest in linacs for this energy centers on two possible applications: first, as injectors for 300 to 1000 Bev synchrotrons, and second, as sources of intense meson beams. To review this progress, a conference jointly sponsored by the Brookhaven National Laboratory and Yale University was held at Brookhaven during the week of August 20, 1962.

Monoclinic FeSO4·7H2O is the stable solid phase between -1.82° and 56.6° C in contact with a saturated water solution of FeSO4. It occurs in nature as an oxidation product of Fe-containing sulfides an is called melanterite. FeSO4·7H2O belongs to a series of compounds Me2+SO4·nH2O, where Mn2+ is a cation with an approximate ionic radius of 0.7Å. The 1-, 4- and 5-hydrates are known to crystalize each in only one form, whereas the hexa- and the heptahydrates occur both in two different forms. The crystal structure of the tetragonal NiSO4·6H2O; Zalkin, Ruben and Templeton reported the structure of the monoclinic CoSO·6H2O. Of the structure of the heptahydrates but one was described: the orthorhombic form of NiSO4·7H2O. No details were known about one of the monoclinic heptahydrates, though Leonhardt and Ness published the cell constants and the space group of FeSO4·7H2O.. In addition they stated essentially correct positional parameters for the sulfur atom and gave the correct positions of the iron atoms. The present investigation has been undertaken as part of an extensive study of salt hydrates. A preliminary account has been published before.

The author presents a literature review of the clinical and experimental investigations into hypertension and phenomena associated with high blood pressure. The author discusses the topics of heredity, angiotensin-aldosterone system, vascular reactivity, ionic gradient and blood pressure, morphological changes, the kidney, sodium, the nervous system, catecholamines, the adrenal cortex, thyroid, antidiuertic hormone, ions other than sodium, obesity, aging, and atherosclerosis and their potential roles in hypertension. The author concludes that while far from understanding hypertension completely, several metabolic abnormalities have been discovered to be associated with hypertension and even play a "causal" role. He suggests that we should look much earlier in the life history of a hypertensive for etiological factors and subtle metabolic abnormalities than we do today.

This report, presented at the annual meeting of the Gerontological Society on November 10, 1961, expands on the research of Becquerel and Curies radioactive isotopes in medicine.